Your session is about to expire
← Back to Search
NightWare for PTSD
Study Summary
This trial will test whether a new app can help improve symptoms for people with PTSD who have nightmares.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have been diagnosed with PTSD according to the DSM-5.People who do not smoke.I don't take vitamins or anti-inflammatory drugs, or I can stop them a month before the vascular visit.You have been diagnosed with PTSD according to the guidelines in the DSM-5.Your Pittsburgh Sleep Quality Index (PSQI) score is 6 or more.Your blood sugar level while fasting is less than 126 mg/dL.Your PSQI score is 6 or more.I don't take vitamin supplements or anti-inflammatory meds, or I can stop them a month before the vascular visit.This criterion states that the participant must have access to wireless internet and two power outlets where they sleep.My high blood pressure is not under control.I am older than 22 years.I often have nightmares that disturb my sleep.I am older than 22 years.If you feel drowsy when driving, you cannot join the study for safety reasons.I have used hormone therapy in the last 6 months and am postmenopausal.I have been diagnosed with narcolepsy.I have been diagnosed with or suspected to have dementia.I have moderate to severe sleep apnea diagnosed or confirmed by a WatchPat test.I often have nightmares that disturb my sleep.I am currently taking varenicline, beta-blockers (not eye drops), or non-dihydropyridine medications.I have diabetes.I have no current or past cardiovascular diseases, active infections, or cancers (except for skin cancer).I have not had a substance or alcohol use disorder in the past year.I have stopped taking prazosin for 2 days before joining the study.I often have nightmares that disturb my sleep.People who do not smoke.Your blood pressure when you are not active is less than 160/100 mmHg.
- Group 1: Sham NightWare
- Group 2: NightWare
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the participant capacity of this clinical trial?
"Affirmative. Clinicaltrials.gov affirms that this trial is actively enrolling participants, having been first published on June 24th 2022 and most recently updated on August 12th 2022. To date, 50 people have registered to take part at two different sites."
Are senior citizens included in the parameters of this research endeavor?
"Based on the trial's criteria for patient enrollment, those aged between 22 and 99 years of age are eligible to participate."
Are there any vacancies left for enrollees in this trial?
"According to clinicaltrials.gov, this study is currently recruiting patients with the trial having been posted on June 24th 2022 and last updated on August 12th of that same year."
Could I potentially become a participant in this research?
"For this medical experiment, 50 individuals afflicted with PTSD aged between 22 and 99 will be accepted. To meet the eligibility requirements for admission, applicants must have a formal diagnosis of Post Traumatic Stress Disorder matching that detailed in Diagnostic and Statistical Manual of Mental Disorders' (DSM-5) fifth edition; recurrent nightmares affecting sleep quality; blood pressure lower than 160/100 mmHg while at rest; fasted glucose level below 126 mg/dL; no smoking history or use of dietary supplements or anti-inflammatory medications one month preceding enrollment into trial; Pittsburgh Sleep Quality Index scores above 6 and Epworth Sleepiness Scale results higher than 0"
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger